(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 76.64%-16.41K | 429.75%18.71K | 44.17%-32.58K | 26.65%-178.45K | 67.99%-44.14K | -1,623.77%-70.28K | 91.06%-5.67K | -54.35%-58.36K | -20.27%-243.29K | -194.47%-137.91K |
Net income from continuing operations | 92.78%-2.7K | 111.66%4.56K | 28.87%-24.25K | 60.52%-166.72K | 6.42%-56.07K | 55.46%-37.44K | 81.63%-39.12K | 47.87%-34.08K | -95.57%-422.31K | 41.63%-59.92K |
Asset impairment expenditure | ---- | ---- | ---- | --7.43K | ---- | ---- | ---- | ---- | --0 | ---- |
Remuneration paid in stock | -20.72%1.81K | -44.95%3.7K | -49.06%4.86K | -66.56%26.06K | -54.76%7.53K | -80.48%2.29K | -69.50%6.71K | -65.41%9.53K | -8.10%77.93K | -61.38%16.65K |
Change In working capital | 55.80%-15.52K | -60.90%10.45K | 60.97%-13.19K | -144.74%-45.22K | 96.80%-3.03K | -151.45%-35.12K | -79.02%26.74K | -225,486.67%-33.81K | 241.39%101.08K | -844.90%-94.64K |
-Change in receivables | --0 | -84.28%2.08K | 40.15%-875 | 219.88%11.88K | 174.24%709 | 76.58%-598 | 297.48%13.23K | -590.60%-1.46K | -1,296.86%-9.91K | 47.96%-955 |
-Change in prepaid assets | ---- | ---- | ---- | -24.78%853 | ---- | ---- | ---- | ---- | 393.78%1.13K | --0 |
-Change in payables and accrued expense | 55.82%-15.52K | -40.69%8.37K | 61.91%-12.32K | -152.76%-57.96K | 95.15%-4.59K | -154.25%-35.14K | -89.72%14.12K | -1,376.98%-32.35K | 257.09%109.86K | -776.49%-94.74K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 76.64%-16.41K | 429.75%18.71K | 44.17%-32.58K | 26.65%-178.45K | 67.99%-44.14K | -1,623.77%-70.28K | 91.06%-5.67K | -54.35%-58.36K | -20.27%-243.29K | -194.47%-137.91K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | 63.38%-2.68K | 27 | 66.99%-2.42K | 34.81%-7.33K | 0 | ||||
Net PPE purchase and sale | --0 | ---- | ---- | 63.38%-2.68K | --27 | 66.99%-2.42K | ---- | ---- | 34.81%-7.33K | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --0 | ---- | ---- | 63.38%-2.68K | --27 | 66.99%-2.42K | ---- | ---- | 34.81%-7.33K | --0 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | -27.25%145.5K | -85.86%28.28K | 93.23K | -39.10%200K | 200K | ||||
Net common stock issuance | ---- | ---- | ---- | -27.25%145.5K | -85.86%28.28K | ---- | ---- | ---- | -31.03%200K | --200K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --0 | ---- | ---- | -27.25%145.5K | -85.86%28.28K | --93.23K | ---- | ---- | -39.10%200K | --200K |
Net cash flow | ||||||||||
Beginning cash position | -30.28%21.09K | -80.53%2.38K | -50.47%34.97K | -41.76%70.6K | 497.21%50.8K | 51.94%30.25K | -85.33%12.24K | -41.76%70.6K | 1,912.20%121.22K | -95.25%8.51K |
Current changes in cash | -179.96%-16.41K | 3.74%18.71K | 44.17%-32.58K | 29.61%-35.63K | -125.50%-15.83K | 280.01%20.53K | 128.40%18.04K | -54.35%-58.36K | -144.06%-50.62K | 206.92%62.09K |
End cash Position | -90.79%4.68K | -30.28%21.09K | -80.53%2.38K | -50.47%34.97K | -50.47%34.97K | 497.21%50.8K | 51.94%30.25K | -85.33%12.24K | -41.76%70.6K | -41.76%70.6K |
Free cash from | 77.42%-16.41K | 413.66%18.71K | 44.17%-32.58K | 27.73%-181.13K | 68.01%-44.11K | -537.47%-72.7K | 90.61%-5.97K | -54.35%-58.36K | -17.38%-250.62K | -137.48%-137.91K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data